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The human Intestinal mucus is formed by glycoproteins, the O- and N-linked
glycans which constitute a crucial source of carbon for commensal gut bacteria,
especially when deprived of dietary glycans of plant origin. In recent years, a
dozen carbohydrate-active enzymes from cultivated mucin degraders have been
characterized. But yet, considering the fact that uncultured species predominate in the
human gut microbiota, these biochemical data are far from exhaustive. In this study,
we used functional metagenomics to identify new metabolic pathways in uncultured
bacteria involved in harvesting mucin glycans. First, we performed a high-throughput
screening of a fosmid metagenomic library constructed from the ileum mucosa
microbiota using chromogenic substrates. The screening resulted in the isolation of
124 clones producing activities crucial in the degradation of human O- and N-glycans,
namely sialidases, β-D-N-acetyl-glucosaminidase, β-D-N-acetyl-galactosaminidase,
and/or β-D-mannosidase. Thirteen of these clones were selected based on their
diversified functional profiles and were further analyzed on a secondary screening.
This step consisted of lectin binding assays to demonstrate the ability of the clones
to degrade human intestinal mucus. In total, the structural modification of several
mucin motifs, sialylated mucin ones in particular, was evidenced for nine clones.
Sequencing their metagenomic loci highlighted complex catabolic pathways involving
the complementary functions of glycan sensing, transport, hydrolysis, deacetylation, and
deamination, which were sometimes associated with amino acid metabolism machinery.
These loci are assigned to several Bacteroides and Feacalibacterium species highly
prevalent and abundant in the gut microbiome and explain the metabolic flexibility of gut
bacteria feeding both on dietary and human glycans.
Keywords: functional metagenomics, carbohydrate-active enzymes, human intestinal mucin, human gut
microbiota, lectin binding
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INTRODUCTION
The human intestinal tract harbors a dense commensal microbial
community whose interactions with the host are of paramount
importance for its health and well-being, particularly for the
development of immunity and protection against invasion by
pathogens. One of the best-known functions of the microbiota is
its contribution to the digestion of dietary fibers, derived mainly
from plant cell walls. Dietary fibers, consisting of polysaccharides
of great structural diversity, represent the main energy source for
the microbiota. The majority of gut bacterial species possess an
enzymatic arsenal in the form of carbohydrate-active enzymes
(CAZymes; Lombard et al., 2014) used to depolymerize these
fibers. The products are further fermented to provide Short
chain fatty acids (SCFAs) to the host. By contrast CAZymes
produced by the human digestive system can only act on
digestible starch and some other simple sugars such as sucrose
or lactose (El Kaoutari et al., 2013). In addition to dietary
fibers, intestinal microorganisms use glycans associated with
human glycoproteins as a source of energy in particular mucin
glycans that are secreted by the goblet cells of the intestinal
epithelium. Mucin glycoproteins contain a large panel of mostly
O-linked, and some N-linked, glycan structures (Podolsky, 1985;
Robbe et al., 2004). Mucins represent a protective barrier for the
intestine that is perpetually renewed. Mucus-colonizing bacteria
produce both proteins to adhere to mucins and enzymes to
degrade them (Tailford et al., 2015). The enzymatic machinery
of these bacteria allows mucins to be recycled.
In recent years, growth assays on pig and human mucins,
combined with pioneering genomic and transcriptomic studies,
have shown that a number of pathogens and commensals
(Tailford et al., 2015; Martens et al., 2018), including several
Bacteroides species (Bäckhed et al., 2005; Sonnenburg et al.,
2005; Martens et al., 2008; Marcobal et al., 2013), Ruminococcus
gnavus (Owen et al., 2017) and the probiotic species Akkermansia
muciniphila (Derrien et al., 2004), are involved in mucin
degradation. This was especially described in cases of dietary fiber
deprivation, when certain commensals shift their metabolism
from dietary to host glycans (Desai et al., 2016). Furthermore,
recent studies have also shown correlations between host diet,
a reduction in mucus thickness, microbiota composition, and
inflammatory bowel diseases (ulcerative colitis and Crohn’s
disease) and colorectal cancers (Pickard et al., 2014; Jakobsson
et al., 2015; Desai et al., 2016). Despite these recent advances,
only a dozen CAZymes (reviewed in Tailford et al., 2015) have
been biochemically proven to degrade mucin oligosaccharides,
and our understanding of mucin glycan-degrading pathways
is almost exclusively restricted to cultured species. To date,
only one enzyme has been characterized as involved in the
degradation of human N-glycans by an uncultured gut bacterium
(Ladevèze et al., 2013, 2015). Considering the fact that the
majority of microbiota species are still uncultured, the studies
so far conducted into the degradation of human glycans by gut
bacteria are thus far from exhaustive.
In this study, we used functional metagenomics to identify
mucin-degrading pathways from the uncultured fraction of
the human gut microbiota. A two-step activity-based screening
strategy was applied to search for mucin catabolic pathways
in a mucosal ileal metagenomic library, and to demonstrate
their involvement in the structural modification of human colon
mucus. Genomic and metagenomic data were integrated to
assess the abundance and prevalence of these mucin glycan
utilization loci in the human gut microbiome, and to reveal
synteny with genomic loci from reference gut bacteria, which
had not previously been proven to be involved in these
host–microbiota relationships.
MATERIALS AND METHODS
Metagenomic DNA Sampling and Library
Construction
Bacterial metagenomic DNA was obtained from the distal ileum
sample of a 50-55-year-old patient undergoing colonoscopy and
surgery for a suspected cancer of the lower colon after patient
had been subjected to a cleansing preparation. The patient did
not receive any antibiotics or other drugs in the 6 months
before sampling. The sampling protocol was approved by the
local ethics committee: the Comité de Protection des Personnes
Sud Est V (Ref.: 07-CHUG-21; B. Habozit, J. L. Crakowski, J.
Juge, J. Grunwald, E. Svhan, and E. Fontaine on the committee).
A segment of 2 cm2 was obtained from a healthy zone, before
being immediately frozen and kept at −80◦C until processing.
The ileal mucosa was scraped, an enriched bacterial fraction
was recovered using the method described in Courtois et al.
(2003), and the metagenomic DNA was extracted as described in
Tasse et al. (2010). Fragments of between 30 and 40 kb in size
were isolated and cloned into the pCC1FOS fosmid (Epicenter
Technologies). EPI100 E. coli cells were then transfected to obtain
a library of 20,000 clones. Recombinant clones were transferred
to 384-well microtiter plates containing a Luria-Bertani (LB)
medium, supplemented with 12.5 mg/L chloramphenicol and 8%
(w/v) glycerol. They were grown for a period of 22 h at 37◦C
and then frozen and conserved at−80◦C. All other culture media
mentioned in this study contained 12.5 mg/L chloramphenicol.
Metagenomic Library Screening
The library was gridded using an automated microplate gridder
(K2, KBiosystem, Basildon, United Kingdom) on 22 cm× 22 cm
trays containing a solid agar medium supplemented with
12.5 mg/L chloramphenicol and with chromogenic substrates
at a final concentration of 60 µg/mL (w/v). The chromogenic
substrates used – 5-Bromo-4-chloro-3-indolyl a-L-fucopyrano
side (X-α-L-Fuc), 5-Bromo-4-chloro-3-indolyl 2-acetamido-2-
deoxy-b-D-glucopyranoside (X-β-D-GlcNac), 5-Bromo-4-chl
oro-3-indolyl N-acetyl-a-D-neuraminic acid (X-α-D-Neu5Ac),
5-Bromo-4-chloro-3-indolyl 2-acetamido-2-deoxy-b-D-galactop
yranoside (X-β-D-GalNac), 5-Bromo-4-chloro-3-indolyl a-D-
mannopyranoside (X-α-D-Man), and 5-Bromo-4-chloro-3-
indolyl b-D-mannopyranoside (X-β-D-Man) – were purchased
from Carbosynth1. The plates were incubated at 37◦C for periods
1https://www.carbosynth.com
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of between 1 day and 2 weeks, depending on the time needed to
observe the blue-colored clones.
Lectin Binding Experiments
On the basis of their multiple activities on the chromogenic
X-substrates from the primary screening, a selection of hit clones
were tested for their ability to degrade human colon mucus
using lectin binding assays. The hit clones were grown at 37◦C
in 400 mL LB medium, with orbital shaking at 120 rpm. After
16 h, cells were harvested using centrifugation for 5 min at
5,000 rpm, before being re-suspended and concentrated in an
activity buffer (RPMI medium from Sigma) to obtain a final
OD600 nm of 80. Cell lysis was carried out using sonication.
Cell debris were centrifuged at 13,000 rpm for 10 min and
cytoplasmic extracts were filtered using a 0.20 µm Minisart RC4
syringe filter. An E. coli EPI100 clone containing the pCC1FOS
fosmid without a metagenomic DNA fragment was used as a
negative control. The human colon mucus was isolated from
three patients of both genders, 31–74 years of age and all of
European origin as previously described (Ajandouz et al., 2016).
The sampling procedures were approved by the French Ethics
Committee (CODECOH no. DC-2011-1319). Samples were
taken from a macroscopically unaffected area as identified by
the surgeon. After resection, the specimens were placed in
an ice-cold DMEM solution supplemented with antibiotics.
After longitudinal opening of the intestine, the surface of the
mucosa was scraped in PBS to collect intestinal mucus. The
mucus from the three patients was pooled and stored at −80◦C
until used. A lectin binding assay was used to test the effect of
bacterial enzymes expressed by the positive clones on human
mucins. Briefly, 96-well plates (F-Bottom, Nunc Maxisorp R©)
were coated overnight at 4◦C with 100 µL of human mucins
(5 µg/mL) diluted in a pH 9.6 bicarbonate/carbonate coating
buffer (100 mM). After two washes with 200 µL phosphate saline
buffer (pH 7.4) supplemented with Tween20 0.02% (v/v; PBS-T),
the plates were incubated at 37◦C with 100 µL of the bacterial
supernatant (dilution: 1/100) for 5 h. The wells were washed twice
with 200 µL PBS-T before being saturated at room temperature
for 1 h with 200 µL PBS containing 1% BSA (PBS-B). Finally, the
wells were washed twice with 200 µL PBS-Tween, and 100 µL
of fluorescein-labeled lectin solution (5 µg/mL) in PBS-B were
added. The fluorescein-conjugated lectins used (all from Vector
Laboratories, France) were: Concanavalin A (Con A; selective of
Manα2/6/3-manβ4-Glc(Nac)-R > α-Man > α-Glc > αGlcNAc),
Sambucus nigra (soybean) agglutinin (SNA; selective of
Neu5Acα1/6 Gal(NAc)-R) and Triticum vulgaris (wheat germ)
agglutinin (WGA; selective of Galβ4-GlcNacβ6/3-Galβ4-
R > GlcNAcβ-R > Neu5Acα3/6/8-R). After 1 h incubation at
37◦C, the wells were washed and the fluorescence measured
at an excitation/emission of 490 nm using a BioTek Synergy
HTX Multi-Mode Microplate Reader (BioTek, France). Each
binding experiment for a given lectin was performed in
triplicate, using the same microplate for all hit clones including
three control clones (E. coli host strain transformed with the
empty vector Epi100).
The mean fluorescence value for the three control clones,
corresponding to 100% binding, was used to calculate the
percentage of the lectin binding for each clone, including the
three control clones. The variance within biological replicates
of each clone was first assessed using the F-test against control
clones. Subsequently, p-values were calculated using the t-test to
evaluate the statistical significance of differences between a given
clone and the controls. P-values lower than 0.05 were considered
statistically significant.
Metagenomic Sequence Analysis
The fosmid DNA of the clone hits was extracted using the
NucleoBond Xtra Midi kit from Macherey-Nagel (France).
Fosmids were then sequenced using the Ion Torrent S5 System
at the GeT-Biopuces Platform (Toulouse, France). Read assembly
was performed using Masurca2. The assembled contigs were
cleaned from the pCC1FOS vector sequence using Crossmatch3.
ORF detection and functional annotation was performed using
the RAST annotation server4 (Aziz et al., 2008). CAZyme
encoding genes were identified by BLAST analysis of the
predicted ORFs against the full-length sequences of glycoside
hydrolases (GH), polysaccharide lyases (PL), carbohydrate
esterases (CE), carbohydrate-binding modules (CBM), and
glycosyltransferases (GT) included in the CAZy database5, using a
cut-off E-value of 7·10-6. Sequences that aligned over their entire
length with a sequence in the database with >50% identity were
directly assigned to the same family as the subject sequence. The
remaining ones were subjected in parallel to (i) a BLAST search
against a library built with partial sequences corresponding to
individual GH, PL, CE, CBM, and GT modules and (ii) a
HMMER2 search using Hidden Markov models (HMM2) built
for each CAZy module family, allowing a view of CAZyme
modularity (Lombard et al., 2014). The contigs’ entire nucleotidic
sequences were blasted against the non-redundant database of
the NCBI and against each other to examine their divergence
from the reference strain genomes, and the redundancy between
clone hits. Taxonomic assignation of the metagenomic sequences
was determined using the PhyloPythias program6 (model type:
Generic 2013–800 Genera). The same results were obtained with
a minimum slice at 3% and 50%. The presence of signal peptide
cleavage sites in ORF amino acid sequences were predicted using
the SignalP server7 (Nielsen, 2017).
Prevalence Analyses
The homolog sequences of the translated ORFs were searched
for in the translated catalog of 9.9 million reference genes using
BLASTP (E-value = 0, identity ≥ 90%). This catalog consisted
of the gut metagenomic sequences of 1,267 subjects from three
continents (United States, China and Europe): 139 US HMP
samples, 760 European fecal samples from the MetaHIT project
and 368 Chinese fecal samples (Li et al., 2014). The microbial
gene richness in the human gut was assessed by recovering
2http://www.genome.umd.edu/masurca.html
3http://bozeman.mbt.washington.edu/phredphrapconsed.html
4http://rast.nmpdr.org/
5http://www.cazy.org
6http://phylopythias.bifo.helmholtz-hzi.de
7http://www.cbs.dtu.dk/services/SignalP/
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the occurrence frequency data of homologous sequences of the
catalog from the 9.9 million gene frequency table in the 1,267
subjects8. The frequency values have no unit. They are normalized
to account for sampling and sequencing biases generated by the
diverse origins of the cohorts constituting the catalog.
Data Deposition
The datasets generated in the course of this study are
available in the repository of the DDBJ/EMBL/GenBank
Nucleotide Sequence Database under accession numbers
LR131274-LR1312869.
RESULTS AND DISCUSSION
Screening the Human Gut Metagenome
for Mucin Glycan-Degrading Activities
The 20,000 clones of the E. coli fosmid library constructed
from the ileum mucosa microbiota, covering in total 0.7 Gb
of metagenomic sequence, were screened for nearly all the
α- and β-glycosidase activities required for the degradation
of N- and O-glycans. Firstly, α-L-fucosidases, β-D-N-
acetyl-glucosaminidases, β-D-N-acetyl-galactosaminidases,
α-D-neuraminic-acid hydrolases, α-D- and β-D-mannosidases
were searched for using chromogenic reagents (5-Bromo-4-
chloro-3-indoxyl-glycosyl, known as X-glycosyl substrates) in a
rich solid medium on which the metagenomic clones had been
gridded. It was not possible to screen for β-D-galactosidases
using this approach due to the high background activity of the
E. coli host.
These 120,000 assays allowed 158 validated activities to be
identified, with this corresponding to 124 positive clones, since
40 clones produced several of the screened activities (Table 1).
Strikingly, no positive clone was found on the fucosyl substrate,
despite α-linked-L-fucosyl residues frequently being found at the
non-reducing end of O-linked oligosaccharides, and α-fucosidase
activity being widespread in gut bacteria whatever their taxa
(Katayama et al., 2005; Tailford et al., 2015). This may be due
to the fact that α-fucosidases are known to be inactive on this
kind of artificial substrate (Katayama et al., 2005). The hit yields
varied from 0.1% (for X-α-D-Man) to 3.3% (for X-β-D-GlcNac)
depending on the screening substrate, which is on average
2.2 times higher than the hit rate (0.4–1.3%) obtained when
screening the same library for dietary fiber hydrolytic activities
(Cecchini et al., 2013).
Assessment of Human Intestinal Mucus
Degradation
Since chromogenic substrates do not represent the structural
complexity of mucin oligosaccharides, we then confirmed
the activity of the hit clones on the physiological substrate
targeted by mucus-degrading bacteria. From the 124 positive
clones, we selected 13 to be tested on human intestinal
8http://meta.genomics.cn/meta/dataTools
9https://www.ncbi.nlm.nih.gov/genbank/
mucus and/or sequenced. The clones chosen were those: (i)
producing complementary glycosidase activities required to
break down complex mucin oligosaccharide structures thanks
to the expression of several CAZy-encoding genes clustering in
the same metagenomic loci, or thanks to the production of a
highly promiscuous CAZyme; and (ii) producing the highest
levels of activity, defined as those with the quickest response to
chromogenic testing.
The mucus-degrading ability of the metagenomic clones was
assessed using the ELISA assay technique, which involves the
modification of mucin-specific lectin binding if the epitopes are
affected by CAZyme activity. The mucus was incubated with
the hit clones’ cytoplasmic extracts. After a washing step, it
was then incubated with three fluorescent lectins specific to
different N- and O-glycan motifs (Table 2). A comparison of
lectin binding percentages with those obtained for reference
clones (E. coli host strain transformed with the empty vector
Epi100) is provided in Figure 1 and Table 2. We observed
considerable variability in the binding inhibition values, likely
due to the heterogeneousness of the glycan structures in the
human mucus samples. Nevertheless, binding modification was
significant for several clone–lectin couples. Overall, most of the
TABLE 1 | Results of primary screening.
Substrates Number of
positive clones –
Hit rate
X-β-D-GalNac 47 – 2,3h
X-β-D-GlcNac 67 – 3,3h
X-α-D-Man 2 – 0,1h
X-α-D-Neu5Ac 27 – 1,3h
X-β-D-Man 17 – 0,8h
X-α-L-Fuc 0
Single activities Number of
positive clones
X-β-D-GalNac 15
X-β-D-GlcNac 29
X-α-D-Man 1
X-α-D-Neu5Ac 20
X-β-D-Man 9
Multiple activities Number of
positive clones
X-β-D-Man + X-α-D-Neu5Ac 2
X-β-D-GlcNac +
X-α-D-Neu5Ac
1
X-β-D-GlcNac + X-β-D-Man 2
X-β-D-GlcNac + X-β-D-GalNac 27
X-β-D-GlcNac + X-α-D-Man 1
X-β-D-GlcNac + X-β-D-GalNac
+ X-β-D-Man
1
X-β-D-GlcNac + X-β-D-GalNac
+ X-α-D-Neu5Ac
3
X-β-D-GlcNac + X-α-D-Man+
X-β-D-Man
2
X-β-D-GlcNac + X-β-D-GalNac
+ X-α-D-Neu5Ac + X-
β-D-Man
1
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FIGURE 1 | Lectin binding on human colon mucus after incubation with the clone extracts, compared to reference clones (E. coli host strain transformed with the
empty vector Epi100; ∗, significant modification of lectin binding).
selected clones, except 13P9 and 33D18, induced a decrease in
binding of at least one lectin. The effects were particularly clear
for the clones producing activities that target the β-D-GalNAc,
β-D-GlcNAc, and α-D-Neu5Ac residues usually found at the
terminal extremities of human mucin glycans, which are the most
accessible to exo-acting glycosidases. In most cases, the hit clones
produced the activities required to degrade the glycan structures
targeted by the specific lectins, thus affecting lectin binding.
With respect to the WGA lectin, which is specific to terminal
Galβ4-GlcNacβ6/3-Galβ4-R>GlcNAcβ-R, and to a lesser extent,
Neu5Acα3/6/8-R motifs, five β-D-N-acetyl-glucosaminidase-
producing clones (9D11, 14N11, 39E18, 3I21, and 12O6) induced
less lectin binding than was obtained for the reference clones.
The terminal Galβ4 residues were likely removed by the E. coli
β-galactosidase activity, facilitating access to the β-D-N-acetyl-
glucosaminidases produced by the hit clones. Binding of the
SNA lectin, which is specific to terminal Neu5Acα1/6 Gal(NAc)-
R motifs, was reduced after the action of five clones active on
X-α-D-Neu5Ac (20L12, 47G11, 3I21, 40B3, and 39O22) and,
surprisingly, clone 9D11, which is not active on X-α-D-Neu5Ac.
Also surprisingly, ConA lectin binding, which is specific to
Manα2/6/3-manβ4-Glc(Nac)-R > α-Man > α-Glc > αGlcNAc
motifs, was inhibited after the action of two clones (40B3 and
12O6) which were not detected as being active on X-α-Man.
We cannot exclude the possibility that these clones do indeed
produce the enzymes required to break down the glycan motifs
targeted by ConA, but that their activity cannot be detected on
the corresponding X-glycosyl substrates due to the structural
modification of the aglycon in chromogenic substrates. Another
explanation could be the production by the hit clones of cell wall
anchors or glycoprotein adhesins (as further explained in this
paper regarding 9D11 sequence annotation), which may compete
for binding with mucin-specific lectins.
Identification of Mucin Glycan Utilization
Loci
The metagenomic DNA from the 13 clones was sequenced using
a high sequencing depth (100X) to ensure reliable sequence
assembly. For each clone, one contig of between 27,897 and
50,904 bp in size was obtained. In total, 794,676 bp (containing
316 ORFs) were analyzed. Of these 316 ORFs, 56 were annotated
as CAZyme encoding genes.
Forty-nine of these predicted CAZymes contained a GH
module (Supplementary Table S1), and a further four were
esterases. In most of the contig sequences, the CAZyme-encoding
genes were organized in operon-like multigenic systems similar
to the polysaccharide utilization loci (PULs) described for
cultivated species (Terrapon et al., 2018) and other metagnomic
DNA fragments (Tasse et al., 2010; Supplementary Table S1).
The metagenomic PULs retrieved in the present study code for
the batteries of CAZymes, carbohydrate sensing/binding proteins
and transporters required to achieve the complete breakdown
and uptake of mucin glycans. The structural modification of
mucin glycans results from the production of several glycosidase
activities that could be inferred from the GH families highlighted
in their sequences (Table 2 and Supplementary Table S1),
and which are all required for the degradation of complex
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mucin glycans. Most of the GH sequences presented the signal
peptide sequences, indicating their membrane or extracellular
location in the bacteria they originate from, necessary to
initiate the breakdown of complex glycan structures into simpler
oligosaccharides, which are very likely internalized thanks to
the various carbohydrate transporters we identified (annotated
as ABC transport family, MFS, SusD/SusC systems or outer
membrane eﬄux protein). As with canonical Bacteroidetes PULs,
we also identified other genes coding for proteins involved
in the regulation of gene expression in these metagenomic
loci (AraC family transcriptional regulator, chemotaxis protein
CheY/response regulator receiver domain protein). Finally,
as described in greater detail later in this section, we also
identified in these loci several genes coding for putative enzymes
involved in central carbohydrate metabolism, especially sialic
acid metabolism.
Partial or complete sequence redundancy was observed in
clones 14N11, 20L12, 47G11, and 39E18, in clones 3I21, 40B3
41E6, and 39O22, in clones 12O6 and 47C24, and in clones 13P9
and 33D18 (Figures 2A–D, respectively). These 12 sequences
finally correspond to four loci, all assigned to the Bacteroides
genus using PhyloPythiaS which is in agreement with the
syntenies detailed hereafter.
Locus A Assigned to Bacteroides
vulgatus or Bacteroides massiliensis
The three partially redundant sequences of the
sialidase-, β-D-NAcetylgalactosaminidase- and/or β-D-
NAcetylglucosaminidase-producing clones 14N11, 20L12,
and 39E18 presented high sequence identity (99–100%) onto
their coverage areas (Figure 2A). The 39E18 contig is included in
that of 20L12. The 14N11 and 20L12 sequences can be combined
to form a longer, single contig containing eight GH-encoding
genes assigned to the GH2 (2 sequences), GH20 (3 sequences),
GH27, GH33, and GH92 families. These families all host already
characterized members which are able to depolymerize human
N- and O-glycans; β-galactosidases, β-N-acetylglucosaminidases,
α-N-acetylgalactosaminidases, sialidases and α-mannosidases,
respectively. Synteny was detected between contigs 14N11,
20L12, and 39E18 and a locus from Bacteroides vulgatus ATCC
8482 corresponding to the predicted PUL 67. The synteny with
PUL 67 is, however, disrupted by the insertion of four genes in
the metagenomic DNA (ORFs 13–16 in clone 20L12), including
the GH27 encoding gene and two genes involved in nutrient
binding and transport. This insertion confers an ecological
advantage to the uncultured strain containing this metagenomic
locus over B. vulgatus for O-GalNAc glycan foraging, especially
the core 3 structure from human colonic mucins (Brockhausen
et al., 2009). Sialidase activity was observed for contig 47G11 on
the chromogenic substrate and mucus. This contig contained
a similar gene series to 14N11 and 20L12, albeit with two
additional CAZyme-encoding genes (GH29 and 97), and
shared, respectively 82 and 90% sequence identity with contigs
14N11 and 20L12. The percentage of its CAZyme sequences’
identity with the homologous sequences in contigs 14N11 and
20L12 (79–90%) indicates that these metagenomic fragments
originate from different strains or species. Contig 47G11 indeed
presents an almost perfect synteny with the predicted PUL 4
from B. massiliensis B84634 (100% Cov, 99% ID), but with two
additional genes in the metagenomic sequence.
The B. vulgatus strain ATCC 8482 is one of the most prevalent
strains in the human gut Bacteroides group. It is thought
to be responsible for the development of inflammation and
exacerbated immune response in the pathogenesis of IBD (Shiba
et al., 2003). However, in our study, we found the genes of
contigs 20L12 and 14N11 to be highly prevalent and abundant
in the human gut metagenomic gene catalog, regardless of the
geographic origin or medical status of the subjects (Figure 3
and Supplementary Table S1). The locus identified in this study,
which is not a biomarker of IBD, is thus unlikely to be involved in
IBD. Besides, the B. vulgatus strain ATCC 8482, which is known
to produce a whole panel of glycolytic activities required to
degrade mucus glycoproteins (Ruseler-van Embden et al., 1989),
has previously been found to degrade pig gastric mucin, but not
human mucin glycans (Hoskins et al., 1992; Png et al., 2010).
These data could thus be revisited by more specifically assessing
the growth of this strain on specific structures of sialylated mucin
glycans. As B. vulgatus strain ATCC8482, B. massiliensis B84634
was also reported to be able to grow on pig gastric mucin,
resulting in the activation of six of its 33 PULs, including PUL
4 (Pudlo et al., 2015). The prevalence of the cluster’s genes is
lower than those of corresponding genes in the B. vulgatus strain,
and their abundance is lower in European subjects (Figure 3 and
Supplementary Table S1).
Finally, in the contigs of these sialidase-producing clones,
we also identified genes encoding putative sialic acid-specific 9-
O-acetylesterase, N-acetylglucosamine-6-phosphate deacetylase,
glucosamine-6-phosphate deaminase and sialic acid-induced
mutarotase, constituting the denominated Nan system for
N-acylneuraminate (Vimr et al., 2004; Egan et al., 2014).
Marcobal et al. (2011) stressed that a certain number of
bacterial species do not possess all the enzymes for the complete
catabolism of sialic acid: B. tetaiotaomicron, for example, has
sialidases but not the Nan system to metabolize sialic acid.
Conversely, other species such as Clostridium difficile do not have
sialidases but possess the Nan system to metabolize sialic acid
released by other bacteria. Here, the uncultured bacteria from
which contigs 14N11, 20L12, and 39E18 originated evolved to
cluster all the sialidase-encoding genes and the Nan operon on
the same locus, as well as other CAZyme-encoding genes likely
to release other monosaccharides belonging to the sialylated
mucin glycans. This confers an important ecological advantage
to colonize the mucosal layer.
Locus B Assigned to Bacteroides
plebeius
The four partially redundant sequences 3I21, 40B3, 39O22, and
41E6 have high sequence similarity (99–100%) (Figure 2B).
The 3I21 and 41E6 sequences can be combined to form a
longer, single contig containing seven GH-encoding genes,
including the GH20, GH29, GH33, GH3 families, which are
known to contain members able to depolymerize O-glycans
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FIGURE 2 | Metagenomic loci of the hit clones and syntenies with reference genomes. (A) partial redundancy between clones 14N11, 47G11, 39E18, and 20L12
and their synteny with B. vulgatus ATCC 8482 and B. massiliensis B84634. (B) partial redundancy between clones 3I21, 40B3, 41E6, and 39O22 and their synteny
with B. plebeius DSM 17135. (C) partial redundancy between clones 12O6 and 47C24 and their synteny with B. plebeius DSM 17135. (D) partial redundancy
between clones 13P9 and 33D18 and their synteny with B. uniformis An67. (E) synteny of 9D11 and F. prausnitzii A2-165. In gray, identical genome parts; red
arrows, CAZymes; blue arrows, other enzymes of carbohydrate metabolism; green arrows, transporters; pink arrows, transcription/transduction signal; gray arrows,
others; and red lines, redundant metagenomic sequences.
(β-1,6-N-acetylglucosaminidases, α-L-fucosidases, sialidases).
The remaining GH78-, GH115-, and GH97-encoding genes
belong to another gene cluster best suited to the degradation of
plant glycans, which highlights the probable metabolic flexibility
of the uncultured bacterium from which this metagenomic
DNA fragment originated. The functional profile of the clones
matches their content in GH families (Table 2 and Figure 1).
Additional genes involved in carbohydrate binding and transport
(annotated as substrate-binding protein, SusC/SusD, and major
facilitator family transporter) and gene expression regulation
were also present in these metagenomic sequences. These
contigs present a nearly perfect synteny with the predicted
PUL 9 from the B. plebeius DSM 17135 strain (93% Cov, 98%
Id for 3I21 and 95% Cov, 98% Id for 41E6), although this was
disrupted by the insertion of two genes coding for a GH29
putative α-L-fucosidase (ORF6 in contig 3I21) and one putative
transporter (ORF18 in contig 3I21), adding a complementary
function to the bacterium’s glycan degradation pathway. In
this mucin-targeting metagenomic PUL, GH-encoding genes
were also surrounded by genes conferring complementary
functions for N-acetylhexosamine catabolism and sialylation
processes – methyl transferase, N-acetylneuraminate
cytidylyltransferase, N-acetylneuraminic mutarotase, sialic
acid-specific 9-O-acetylesterase, N-acetylneuraminate lyase and
N-acylglucosamine 2-epimerase – whose roles in carbohydrate
metabolism have previously been described for symbiotic
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FIGURE 3 | Abundance and prevalence of the genes of the contigs in the human gut metagenome. Genes are in rows. Individuals are in columns. The normalized
abundance is represented by a color scale, white, not detected; pink, orange, and red, increasing abundance with a 100-fold change between colors.
and pathogenic bacteria (Vimr and Lichtensteiger, 2002;
Ringenberg et al., 2003; Bravo et al., 2004; Vimr et al., 2004;
Mizanur and Pohl, 2008). This gene cluster thus combines
genes dedicated to the depolymerization of sialylated mucin
glycans with genes involved in the synthesis, activation and
transfer of sialic acid onto bacterial cell surfaces. Such a
process of carbohydrate harvesting and reuse for bacterial
glycan synthesis would permit bacteria to mimic vertebrate cell
surfaces and evade the host’s immune system. In mammals,
sialic acids are widespread molecules usually at the terminal
position of oligosaccharide chains of cell-surface or serum
glycoconjugates. Their functions in regulation of host innate
defense mechanisms make it a key substance for microorganisms
to survive in the environment (Vimr et al., 2004). Although
they were all prevalent in the sample, these metagenomic genes
are not evenly distributed among the population (Figure 3).
Except for one gene (ORF1, contig 41E6), a mobile element
appearing in the heat map as a biomarker of European subjects,
the entire locus (including the additional GH29 compared to
B. plebeius DSM 17135 PUL9) is significantly more abundant
in the European IBD cohort than the healthy cohort. At
the same time, it is abundant and prevalent in the Chinese
subjects, including the healthy ones, and almost absent in the
United States subjects.
Locus C Assigned to Bacteroides
plebeius
Contig 47C24 is included in contig 12O6, with which it shares
99% sequence identity. Contig 12O6 has 98% identity with a
B. plebeius DSM 17135 locus, which includes a part of the
predicted PUL 4 (Figure 2C). This part of PUL 4 contains
one GH20- and three GH2-encoding genes, with the former
gene explaining the β-D-Nacetylgalactosaminidase and β-D-
Nacetylglucosaminidase activities of clones 47C24 and 12O6.
Surrounding the CAZymes, we also found three genes likely
involved in the binding and transport of nutrients. Finally, not
surprisingly, the prevalence and abundance pattern of this locus
was similar to that of contigs 3I21, 40B3, 39O22, and 41E6, which
also showed synteny with other B. plebeius DSM 17135 loci.
Locus D Assigned to Bacteroides
uniformis
The last Bacteroides contig, namely contig 13P9, which includes
sequence 33D18 (Figure 2D), shared 99% identity with a genomic
locus from B. uniformis An67, a strain which is not included in
the PUL database. This metagenomic PUL contains a GH2-, a
GH3-, and a CE7-encoding gene. The GH2 family contains β-D-
mannosidases, explaining activity on X-β-D-Man (Table 2 and
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Figure 1). Due to its position at the end of the contig, the GH3-
encoding gene is truncated and probably not functional here,
but some of the characterized proteins of the family are known
to act on β-N-acetylhexosamines, of which the acetyl groups
could be hydrolysed by the CE7 enzyme. This metagenomic locus
is probably involved in the catabolism of human N-glycans by
uncultured bacteria, and/or B. uniformis strains, which have a
high potential to utilize both dietary (Tasse et al., 2010; Patrascu
et al., 2017) and endogenous glycans (Benítez-Páez et al., 2017).
This considerable metabolic flexibility of B. uniformis, which
gives it a significant advantage when it comes to easily colonizing
the human gut ecosystem, could explain why the locus identified
in this study is so prevalent and abundant in the microbiome,
regardless of the geographic origin or medical status of the
individual (Supplementary Table S1 and Figure 3).
Locus E Assigned to Faecalibacterium
prausnitzii
The last metagenomic locus identified here, that of the β-D-
mannosidase and β-N-acetylglucosaminidase clone 9D11, was
assigned to Feacalibacterium using PhylophythiaS. It was indeed
found to share 98% identity with a locus of Faecalibacterium
prausnitzii A2-165 F (Figure 2E). It contains only one
CAZyme-encoding gene (GH1), which was probably responsible
for the activity detected on X-β-Man. Conversely, neither activity
on X-β-GlcNac nor modification of WGA and SNA lectin
binding to mucus could be explained by the presence of this
GH1 enzyme, indicating that one or several of the numerous
putative proteins encoded in this locus (some presenting distant
homologies with adhesins and agglutinins) may perform these
functions, and/or that the encoded GH1 is a highly promiscuous
enzyme, which will have to be characterized. Additionally,
five genes coding for a putative peptidic transport system
(oppABCDF operon) were clustered in this locus. The opp
transport system is involved in peptide uptake for nutrition,
sensing environmental changes and recycling peptides from, for
instance, muropeptides; that is, peptidoglycans from bacterial cell
walls consisting of alternating residues of β-N-acetylglucosamine
(NAG) and N-acetylmuramic acid (NAM) linked to a peptide
chain (Monnet, 2003). In this pathway, peptides internalized
by the oppABCDF system are hydrolysed into amino acids
by a set of peptidases, a role that may have been performed
here by the putative CocE/NonD hydrolase belonging to the
aminopeptidase family identified in the 9D11 locus. With respect
to the functioning of F. prausnitzii in the human gut microbiota,
most strains grew on N-acetylglucosamine, highlighting their
probable ability to utilize host-derived substrates (Lopez-Siles
et al., 2012). This is consistent with the CAZy gene content of the
F. prausnitzii genomes. We indeed found several F. prausnitzii
sequences in the CAZy database that had been assigned to
families as GH2- and GH3-containing members active on
β-D-N-acetylglucosamine, β-D-N-acetylhexosamine and β-D-
glucosamine linkages, although none of these F. prausnitzii
enzymes has been biochemically characterized to date. In any
case, F. prausnitzii is far from being as well equipped with
glycan-degrading enzymes as the Bacteroides species described
above. Nevertheless, our results demonstrate that this species has
the potential to interact with mucus. This could explain the above
mentioned modulation of the effect of B. thetaiotaomicron on the
intestinal mucus barrier, resulting in a modification in goblet cell
differentiation and mucin glycosylation (Wrzosek et al., 2013).
Moreover, F. prausnitzii belongs to the most abundant Firmicutes
species in the human gut, which is consistent with the high
abundance and prevalence of the locus we identified in this
study (Figure 3). The gene abundance heat map indicates a
lower prevalence of 9D11 genes in Chinese subjects, regardless
of their medical status, than in European ones. What is more,
compared to healthy subjects, these genes are more abundant
in the microbiome of patients suffering from ulcerative colitis,
but less abundant in patients with Crohn’s disease (CD). This
is perfectly consistent with the low abundance of F. prausnitzii
in the microbiome of CD patients, particularly those with ileal
involvement (Sokol et al., 2009), which could be connected with
the ability of this species to interact with mucus through its glycan
and proteic fractions, as highlighted here with the 9D11 locus.
CONCLUSION
To conclude, our work constitutes the first activity-based
metagenomic study targeting the glycan-mediated relationships
between the human gut microbiota and the host. Until now,
the identification of bacterial species and metabolic pathways
involved in mucus degradation was restricted to cultured
bacteria, tested for growth on complex mucin glycan structures of
porcine origin. When combined to genomic and transcriptomic
analyses, these studies allowed to identify mucin glycan
utilization loci for the few dozen of targeted strains. Nevertheless,
to date only a very small number of these pathways have been
biochemically proven to degrade human mucin structures.
In the present study, we designed a two-step functional
screening strategy, which allowed us, for the first time, both to
identify mucus degrading pathways from uncultured species of
the microbiota, and to prove their ability to degrade specific
motives of human colonic mucus. The mucin glycan utilization
loci we discovered are highly prevalent and abundant in the
microbiome, and present marked synthenies with loci from
several prominent commensal strains from the Bacteroidetes
and Firmicutes phyla, most of them being known to forage on
dietary glycans, but which had never been described to feed on
mucin glycans. Our data highlight the metabolic flexibility of
these abundant commensals, which would have the ability to
easily redirect their metabolism from dietary polysaccharides to
host-derived glycans, depending on the availability of resources.
In addition, we highlighted the overabundance of certain of these
(meta) genomic loci in the microbiome of patients suffering
from inflammatory diseases. This particular trait, together with
the proof of their involvement in the modification of human
mucus, makes them new targets to study the host response to
the degradation of the mucus firewall, and to elaborate new
strategies to restore gut homeostasis, for example by using
specific functional foods to divert over-abundant mucus foragers
toward dietary glycans.
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